1-8 of 8
Gozewijn D. Laverman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study

Jelle M. Beernink, Frederik Persson, Niels Jongs, Gozewijn D. Laverman, Glenn M. Chertow, John J.V. McMurray, Anna Maria Langkilde, Ricardo Correa-Rotter, Peter Rossing, C. David Sjöström, Robert D. Toto, David C. Wheeler, Hiddo J.L. Heerspink
Journal: Diabetes Care
Diabetes Care 2023;46(3):602–607
https://doi.org/10.2337/dc22-1514
Published: 20 January 2023
View article titled, Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study
Open the PDF for Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study in another window
Journal Articles

Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial

Viktor Rotbain Curovic, Niels Jongs, Marjolein Y.A.M. Kroonen, Emilie H. Zobel, Tine W. Hansen, Taha Sen, Gozewijn D. Laverman, Adriaan Kooy, Frederik Persson, Peter Rossing, Hiddo J.L. Heerspink
Journal: Diabetes Care
Diabetes Care 2023;46(3):593–601
https://doi.org/10.2337/dc22-1699
Published: 18 January 2023
View article titled, Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial
Open the PDF for Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial in another window
Journal Articles

Response to Comment on Oosterwijk et al. High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort. Diabetes Care 2022;45:35–41

Milou M. Oosterwijk, Dion Groothof, Gerjan Navis, Stephan J.L. Bakker, Gozewijn D. Laverman
Journal: Diabetes Care
Diabetes Care 2022;45(3):e69
https://doi.org/10.2337/dci21-0062
Published: 04 March 2022
View article titled, Response to Comment on Oosterwijk et al. High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort. Diabetes Care 2022;45:35–41
Open the PDF for Response to Comment on Oosterwijk et al. High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort. Diabetes Care 2022;45:35–41 in another window
Journal Articles

High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort

Milou M. Oosterwijk, Dion Groothof, Gerjan Navis, Stephan J.L. Bakker, Gozewijn D. Laverman
Journal: Diabetes Care
Diabetes Care 2022;45(1):35–41
https://doi.org/10.2337/dc21-1211
Published: 28 October 2021
View article titled, High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort
Open the PDF for High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort in another window
Journal Articles

Glucose Regulation Beyond HbA1c in Type 2 Diabetes Treated With Insulin: Real-World Evidence From the DIALECT-2 Cohort

Niala den Braber, Miriam M.R. Vollenbroek-Hutten, Kathryn M. Westerik, Stephan J.L. Bakker, Gerjan Navis, Bert-Jan F. van Beijnum, Gozewijn D. Laverman
Journal: Diabetes Care
Diabetes Care 2021;44(10):2238–2244
https://doi.org/10.2337/dc20-2241
Published: 22 July 2021
View article titled, Glucose Regulation Beyond HbA<sub>1c</sub> in Type 2 Diabetes Treated With Insulin: Real-World Evidence From the DIALECT-2 Cohort
Open the PDF for Glucose Regulation Beyond HbA<sub>1c</sub> in Type 2 Diabetes Treated With Insulin: Real-World Evidence From the DIALECT-2 Cohort in another window
Journal Articles

Biochemical Urine Testing of Medication Adherence and Its Association With Clinical Markers in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente (DIALECT)

Jelle M. Beernink, Milou M. Oosterwijk, Kamlesh Khunti, Pankaj Gupta, Prashanth Patel, Job F.M. van Boven, Hiddo J. Lambers Heerspink, Stephan J.L. Bakker, Gerjan Navis, Roos M. Nijboer, Gozewijn D. Laverman
Journal: Diabetes Care
Diabetes Care 2021;44(6):1419–1425
https://doi.org/10.2337/dc20-2533
Published: 23 April 2021
View article titled, Biochemical Urine Testing of Medication Adherence and Its Association With Clinical Markers in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente (DIALECT)
Open the PDF for Biochemical Urine Testing of Medication Adherence and Its Association With Clinical Markers in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente (DIALECT) in another window
Journal Articles

Fibroblast Growth Factor 23 and Mortality in Patients With Type 2 Diabetes and Normal or Mildly Impaired Kidney Function

Stanley M.H. Yeung, S. Heleen Binnenmars, Christina M. Gant, Gerjan Navis, Ron T. Gansevoort, Stephan J.L. Bakker, Martin H. de Borst, Gozewijn D. Laverman
Journal: Diabetes Care
Diabetes Care 2019;42(11):2151–2153
https://doi.org/10.2337/dc19-0528
Published: 05 September 2019
View article titled, Fibroblast Growth Factor 23 and Mortality in Patients With Type 2 Diabetes and Normal or Mildly Impaired Kidney Function
Open the PDF for Fibroblast Growth Factor 23 and Mortality in Patients With Type 2 Diabetes and Normal or Mildly Impaired Kidney Function in another window
Includes: Supplementary data
Journal Articles

Physical Activity in Patients With Type 2 Diabetes: The Case for Objective Measurement in Routine Clinical Care

Nicole Oosterom, Christina M. Gant, Niels Ruiterkamp, Bert-Jan F. van Beijnum, Hermie Hermens, Stephan J.L. Bakker, Gerjan Navis, Miriam M.R. Vollenbroek-Hutten, Gozewijn D. Laverman
Journal: Diabetes Care
Diabetes Care 2018;41(4):e50–e51
https://doi.org/10.2337/dc17-2041
Published: 06 February 2018
View article titled, Physical Activity in Patients With Type 2 Diabetes: The Case for Objective Measurement in Routine Clinical Care
Open the PDF for Physical Activity in Patients With Type 2 Diabetes: The Case for Objective Measurement in Routine Clinical Care in another window